Use of sedatives and analgesics and hospital outcomes in pediatric intensive care: a cohort study

Detalhes bibliográficos
Autor(a) principal: Vieira,Tayná
Data de Publicação: 2022
Outros Autores: Linck-Júnior,Arnildo, Tacla,Mauren Teresa Grubisich Mendes, Ferrari,Rosângela Aparecida Pimenta, Gabani,Flávia Lopes
Tipo de documento: Artigo
Idioma: eng
Título da fonte: BrJP (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922022000200105
Resumo: ABSTRACT BACKGROUND AND OBJECTIVES Continuous infusion sedoanalgesia may favor negative hospital outcomes, thus, the objective was to analyze the relationship between continuous infusion sedoanalgesia and factors such as duration of mechanical pulmonary ventilation (MPV), extubation failure, hospital infections, length of hospitalization, and death in a mixed pediatric intensive care unit (PICU). The aim of this study was to identify the association of the use of sedatives and analgesics in continuous infusion with hospital outcomes through the control of confounding variables. METHODS Retrospective cohort with hospitalizations of children aged zero to 14 years, from 2012 to 2017. Use of continuous sedoanalgesia was considered a factor for the outcomes: duration of MPV, extubation failure, hospital infections (healthcare-associated infections - HCAI, fungal infection and catheter-related bloodstream infection), length of stay in the PICU and hospital, and death. Poisson regression was performed with adjustment by progressive models, with a significance level of 5%, calculation of relative risk (RR) and confidence interval (95% CI). RESULTS A total of 894 hospitalizations were analyzed, with a predominance of males (54.3%), non-malnourished children (70.7%) and without a diagnosis of chronic disease (55.1%). Infants accounted for half of the population. The outcomes that were associated with continuous sedoanalgesia in the final model were: MPV time > 4 days (RR=2.74; 95%CI=1.90-3.93), HCAI (RR=1.91; 95%CI=.32-2.80), fungal infection (RR=2.00; 95%CI=1.12-3.58), length of stay in the PICU > 3 days (RR=1.81; 95%CI=1.51-2.17) and hospital stay > 10 days (RR=1.52; 95%CI=1.27-1.84), and death (RR=0.64; 95%CI=0.43-0.95). CONCLUSION MPV time longer than four days, diagnosis of HCAI, diagnosis of fungal infection, length of stay in the PICU longer than three days, and hospitalization time longer than 10 days were factors more present in children who received continuous infusion of sedoanalgesia. Death, on the other hand, was more related to severity variables than to the use of psychoactive drugs.
id SBED-2_849031df553a068e25100cce55e8996c
oai_identifier_str oai:scielo:S2595-31922022000200105
network_acronym_str SBED-2
network_name_str BrJP (Online)
repository_id_str
spelling Use of sedatives and analgesics and hospital outcomes in pediatric intensive care: a cohort studyAnalgesiaArtificial ventilationCross infectionDeep sedationIntensive Care UnitsLength of stayABSTRACT BACKGROUND AND OBJECTIVES Continuous infusion sedoanalgesia may favor negative hospital outcomes, thus, the objective was to analyze the relationship between continuous infusion sedoanalgesia and factors such as duration of mechanical pulmonary ventilation (MPV), extubation failure, hospital infections, length of hospitalization, and death in a mixed pediatric intensive care unit (PICU). The aim of this study was to identify the association of the use of sedatives and analgesics in continuous infusion with hospital outcomes through the control of confounding variables. METHODS Retrospective cohort with hospitalizations of children aged zero to 14 years, from 2012 to 2017. Use of continuous sedoanalgesia was considered a factor for the outcomes: duration of MPV, extubation failure, hospital infections (healthcare-associated infections - HCAI, fungal infection and catheter-related bloodstream infection), length of stay in the PICU and hospital, and death. Poisson regression was performed with adjustment by progressive models, with a significance level of 5%, calculation of relative risk (RR) and confidence interval (95% CI). RESULTS A total of 894 hospitalizations were analyzed, with a predominance of males (54.3%), non-malnourished children (70.7%) and without a diagnosis of chronic disease (55.1%). Infants accounted for half of the population. The outcomes that were associated with continuous sedoanalgesia in the final model were: MPV time > 4 days (RR=2.74; 95%CI=1.90-3.93), HCAI (RR=1.91; 95%CI=.32-2.80), fungal infection (RR=2.00; 95%CI=1.12-3.58), length of stay in the PICU > 3 days (RR=1.81; 95%CI=1.51-2.17) and hospital stay > 10 days (RR=1.52; 95%CI=1.27-1.84), and death (RR=0.64; 95%CI=0.43-0.95). CONCLUSION MPV time longer than four days, diagnosis of HCAI, diagnosis of fungal infection, length of stay in the PICU longer than three days, and hospitalization time longer than 10 days were factors more present in children who received continuous infusion of sedoanalgesia. Death, on the other hand, was more related to severity variables than to the use of psychoactive drugs.Sociedade Brasileira para o Estudo da Dor2022-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922022000200105BrJP v.5 n.2 2022reponame:BrJP (Online)instname:Sociedade Brasileira para o Estudo da Dor (SBED)instacron:SBED10.5935/2595-0118.20220030-eninfo:eu-repo/semantics/openAccessVieira,TaynáLinck-Júnior,ArnildoTacla,Mauren Teresa Grubisich MendesFerrari,Rosângela Aparecida PimentaGabani,Flávia Lopeseng2022-06-28T00:00:00Zoai:scielo:S2595-31922022000200105Revistahttps://sbed.org.br/publicacoes-publicacoes-bjp/ONGhttps://old.scielo.br/oai/scielo-oai.phpdkt@terra.com.br || dor@dor.org.br2595-31922595-0118opendoar:2022-06-28T00:00BrJP (Online) - Sociedade Brasileira para o Estudo da Dor (SBED)false
dc.title.none.fl_str_mv Use of sedatives and analgesics and hospital outcomes in pediatric intensive care: a cohort study
title Use of sedatives and analgesics and hospital outcomes in pediatric intensive care: a cohort study
spellingShingle Use of sedatives and analgesics and hospital outcomes in pediatric intensive care: a cohort study
Vieira,Tayná
Analgesia
Artificial ventilation
Cross infection
Deep sedation
Intensive Care Units
Length of stay
title_short Use of sedatives and analgesics and hospital outcomes in pediatric intensive care: a cohort study
title_full Use of sedatives and analgesics and hospital outcomes in pediatric intensive care: a cohort study
title_fullStr Use of sedatives and analgesics and hospital outcomes in pediatric intensive care: a cohort study
title_full_unstemmed Use of sedatives and analgesics and hospital outcomes in pediatric intensive care: a cohort study
title_sort Use of sedatives and analgesics and hospital outcomes in pediatric intensive care: a cohort study
author Vieira,Tayná
author_facet Vieira,Tayná
Linck-Júnior,Arnildo
Tacla,Mauren Teresa Grubisich Mendes
Ferrari,Rosângela Aparecida Pimenta
Gabani,Flávia Lopes
author_role author
author2 Linck-Júnior,Arnildo
Tacla,Mauren Teresa Grubisich Mendes
Ferrari,Rosângela Aparecida Pimenta
Gabani,Flávia Lopes
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Vieira,Tayná
Linck-Júnior,Arnildo
Tacla,Mauren Teresa Grubisich Mendes
Ferrari,Rosângela Aparecida Pimenta
Gabani,Flávia Lopes
dc.subject.por.fl_str_mv Analgesia
Artificial ventilation
Cross infection
Deep sedation
Intensive Care Units
Length of stay
topic Analgesia
Artificial ventilation
Cross infection
Deep sedation
Intensive Care Units
Length of stay
description ABSTRACT BACKGROUND AND OBJECTIVES Continuous infusion sedoanalgesia may favor negative hospital outcomes, thus, the objective was to analyze the relationship between continuous infusion sedoanalgesia and factors such as duration of mechanical pulmonary ventilation (MPV), extubation failure, hospital infections, length of hospitalization, and death in a mixed pediatric intensive care unit (PICU). The aim of this study was to identify the association of the use of sedatives and analgesics in continuous infusion with hospital outcomes through the control of confounding variables. METHODS Retrospective cohort with hospitalizations of children aged zero to 14 years, from 2012 to 2017. Use of continuous sedoanalgesia was considered a factor for the outcomes: duration of MPV, extubation failure, hospital infections (healthcare-associated infections - HCAI, fungal infection and catheter-related bloodstream infection), length of stay in the PICU and hospital, and death. Poisson regression was performed with adjustment by progressive models, with a significance level of 5%, calculation of relative risk (RR) and confidence interval (95% CI). RESULTS A total of 894 hospitalizations were analyzed, with a predominance of males (54.3%), non-malnourished children (70.7%) and without a diagnosis of chronic disease (55.1%). Infants accounted for half of the population. The outcomes that were associated with continuous sedoanalgesia in the final model were: MPV time > 4 days (RR=2.74; 95%CI=1.90-3.93), HCAI (RR=1.91; 95%CI=.32-2.80), fungal infection (RR=2.00; 95%CI=1.12-3.58), length of stay in the PICU > 3 days (RR=1.81; 95%CI=1.51-2.17) and hospital stay > 10 days (RR=1.52; 95%CI=1.27-1.84), and death (RR=0.64; 95%CI=0.43-0.95). CONCLUSION MPV time longer than four days, diagnosis of HCAI, diagnosis of fungal infection, length of stay in the PICU longer than three days, and hospitalization time longer than 10 days were factors more present in children who received continuous infusion of sedoanalgesia. Death, on the other hand, was more related to severity variables than to the use of psychoactive drugs.
publishDate 2022
dc.date.none.fl_str_mv 2022-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922022000200105
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922022000200105
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/2595-0118.20220030-en
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
dc.source.none.fl_str_mv BrJP v.5 n.2 2022
reponame:BrJP (Online)
instname:Sociedade Brasileira para o Estudo da Dor (SBED)
instacron:SBED
instname_str Sociedade Brasileira para o Estudo da Dor (SBED)
instacron_str SBED
institution SBED
reponame_str BrJP (Online)
collection BrJP (Online)
repository.name.fl_str_mv BrJP (Online) - Sociedade Brasileira para o Estudo da Dor (SBED)
repository.mail.fl_str_mv dkt@terra.com.br || dor@dor.org.br
_version_ 1754732510839832576